Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 4
2014 2
2015 3
2016 3
2017 5
2018 4
2019 4
2020 5
2021 6
2022 10
2023 7
2024 8
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR Systems for COVID-19 Diagnosis.
Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, Davaran S, Chauhan SC, Danafar H, Kaboli S, Nosrati H, Yallapu MM, Conde J. Rahimi H, et al. ACS Sens. 2021 Apr 23;6(4):1430-1445. doi: 10.1021/acssensors.0c02312. Epub 2021 Jan 27. ACS Sens. 2021. PMID: 33502175 Review.
Curcumin delivery by modified biosourced carbon-based nanoparticles.
Danafar H, Salehiabar M, Barsbay M, Rahimi H, Ghaffarlou M, Arbabi Zaboli K, Faghfoori MH, Kaboli S, Nosrati H, Faghfoori Z. Danafar H, et al. Among authors: rahimi h. Nanomedicine (Lond). 2022 Jan;17(2):95-105. doi: 10.2217/nnm-2021-0225. Epub 2022 Jan 10. Nanomedicine (Lond). 2022. PMID: 35000461
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.
Rashidzadeh H, Danafar H, Rahimi H, Mozafari F, Salehiabar M, Rahmati MA, Rahamooz-Haghighi S, Mousazadeh N, Mohammadi A, Ertas YN, Ramazani A, Huseynova I, Khalilov R, Davaran S, Webster TJ, Kavetskyy T, Eftekhari A, Nosrati H, Mirsaeidi M. Rashidzadeh H, et al. Among authors: rahimi h. Nanomedicine (Lond). 2021 Mar;16(6):497-516. doi: 10.2217/nnm-2020-0441. Epub 2021 Mar 8. Nanomedicine (Lond). 2021. PMID: 33683164 Free PMC article. Review.
The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial.
Saber-Moghaddam N, Nodeh MM, Ghavami V, Rahimi H, Azimi SA, Seddigh-Shamsi M, Kamandi M, Allahyari A, Shariatmaghani SS, Elyasi S, Arasteh O. Saber-Moghaddam N, et al. Among authors: rahimi h. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):4355-4364. doi: 10.1007/s00210-023-02892-w. Epub 2023 Dec 14. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38095652 Clinical Trial.
Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy.
Salehiabar M, Ghaffarlou M, Mohammadi A, Mousazadeh N, Rahimi H, Abhari F, Rashidzadeh H, Nasehi L, Rezaeejam H, Barsbay M, Ertas YN, Nosrati H, Kavetskyy T, Danafar H. Salehiabar M, et al. Among authors: rahimi h. J Control Release. 2023 Jan;353:850-863. doi: 10.1016/j.jconrel.2022.12.004. Epub 2022 Dec 17. J Control Release. 2023. PMID: 36493951
53 results